The general public will subscribe 6.25 million shares, 25 percent of the total offer size of BF Biosciences IPO on October 2nd and 3rd at the strike price of Rs 77.
The general public can subscribe the IPO on 2nd and 3rd October from 9.00 am to 5pm during banking hours. However, in the case of e-IPO, the process continues for 24 hours.
BF Biosciences IPO Receives Overwhelming Response from Investors
The book-building phase of BF Biosciences concluded last week with an oversubscription of 3.4 times.
The IPO received an overwhelming response from institutional investors and high-net worth individuals as the strike price clocked in at Rs 77/share, 40 percent higher than the floor price of Rs 55 and raised Rs 1.93 billion.
Shahid Ali, CEO Arif Habib Limited said that investing in the public offering of BF Biosciences presents a decent opportunity for retail investors to engage with a fundamentally strong company at a more attractive valuation compared to the broader pharmaceutical sector.
This unique positioning allows investors to capitalize on potential growth while benefiting from a favorable entry point.
inDrive, a global mobility and urban services platform, has joined hands with Essa Labs to…
tapmad Entertainment has cemented its position as a pioneer in Pakistan’s digital entertainment space, not…
Airblue, one of the country’s leading private airlines, has announced a 14% discount on selected…
The Pakistan eCommerce Association (PEA) has urged the government to reduce the tax burden on…
From highlighting the need for affordable smartphones and universal internet to pushing for a cashless,…
Kaspersky research findings show that 42% of children surveyed from the Middle East, Turkiye and…
This website uses cookies.
